Invariant NKT cell activation induces late preterm birth that is attenuated by rosiglitazone

Journal of Immunology

Volumn 196, Issue 3, 2016, Pages 1044-1059

  Louis, Derek St ^a,b   Romero, Roberto ^b,c,d,e   Plazyo, Olesya ^a,b   Arenas Hernandez, Marcia ^a,b   Panaitescu, Bogdan ^e   Xu, Yi ^b   Milovic, Tatjana ^a   Xu, Zhonghui ^a,b   Bhatti, Gaurav ^a,b   Mi, Qing Sheng ^e,f   Drewlo, Sascha ^a   Tarca, Adi L ^a,b   Hassan, Sonia S ^a,b   Gomez Lopez, Nardhy ^a,b,e  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

^e WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN; CELL PROTEIN; FATTY ACID BINDING PROTEIN 4; FATTY ACID TRANSPORTER 4; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA-GALACTOSYLCERAMIDE; ANTIDIABETIC AGENT; CYTOKINE; GALACTOSYLCERAMIDE;

ADAPTIVE IMMUNITY; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; DENDRITIC CELL; DISEASE ACTIVITY; DISEASE CONTROL; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; DRUG RESPONSE; FEMALE; FETUS; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMMUNE RESPONSE; IN VIVO STUDY; INFLAMMATORY GENE; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MOLECULAR DYNAMICS; MOLECULAR IMAGING; MOLECULAR PATHOLOGY; MOUSE; NATURAL KILLER T CELL; NEUTROPHIL; NEWBORN; NEWBORN MORTALITY; NONHUMAN; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; SURVIVAL RATE; UPREGULATION; AGONISTS; ANIMAL; BLOOD; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; IMMUNOPHENOTYPING; PREGNANCY; PREMATURITY; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GALACTOSYLCERAMIDES; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; NATURAL KILLER T-CELLS; PPAR GAMMA; PREGNANCY; PREMATURE BIRTH; REAL-TIME POLYMERASE CHAIN REACTION; THIAZOLIDINEDIONES;

EID: 84957683753     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501962     Document Type: Article

References (157)

1. Liu, L., S. Oza, D. Hogan, J. Perin, I. Rudan, J. E. Lawn, S. Cousens, C. Mathers, and R. E. Black. 2015. Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet 385: 430-440.
2. Martin, J. A., B. E. Hamilton, M. J. Osterman, S. C. Curtin, and T. J. Matthews. 2015. Births: final data for 2013. Natl. Vital Stat. Rep. 64: 1-65.
3. Lubow, J. M., H. Y. How, M. Habli, R. Maxwell, and B. M. Sibai. 2009. Indications for delivery and short-term neonatal outcomes in late preterm as compared with term births. Am. J. Obstet. Gynecol. 200: e30-e33.
4. Mwaniki, M. K., M. Atieno, J. E. Lawn, and C. R. Newton. 2012. Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic review. Lancet 379: 445-452.
5. Manuck, T. A., X. Sheng, B. A. Yoder, and M. W. Varner. 2014. Correlation between initial neonatal and early childhood outcomes following preterm birth. Am. J. Obstet. Gynecol. 210: 426.e1-9. doi:10.1016/j.ajog.2014.01.046
6. Behrman R. E., and A. S. Butler, eds. 2007. Preterm Birth: Causes, Conse-quences, and Prevention. National Academies Press, Washington, DC.
7. Blencowe, H., S. Cousens, M. Z. Oestergaard, D. Chou, A. B. Moller, R. Narwal, A. Adler, C. Vera Garcia, S. Rohde, L. Say, and J. E. Lawn. 2012. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 379: 2162-2172.
8. Shapiro-Mendoza, C. K., and E. M. Lackritz. 2012. Epidemiology of late and moderate preterm birth. Semin. Fetal Neonatal Med. 17: 120-125.
9. Goldenberg, R. L., J. F. Culhane, J. D. Iams, and R. Romero. 2008. Epidemiology and causes of preterm birth. Lancet 371: 75-84.
10. Romero, R., S. K. Dey, and S. J. Fisher. 2014. Preterm labor: one syndrome, many causes. Science 345: 760-765.
11. Romero, R., M. Sirtori, E. Oyarzun, C. Avila, M. Mazor, R. Callahan, V. Sabo, A. P. Athanassiadis, and J. C. Hobbins. 1989. Infection and labor. V. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes. Am. J. Obstet. Gynecol. 161: 817-824.
12. Romero, R., C. Avila, U. Santhanam, and P. B. Sehgal. 1990. Amniotic fluid interleukin 6 in preterm labor. Association with infection. J. Clin. Invest. 85: 1392-1400.
13. Romero, R., R. Quintero, J. Nores, C. Avila, M. Mazor, S. Hanaoka, Z. Hagay, L. Merchant, and J. C. Hobbins. 1991. Amniotic fluid white blood cell count: a rapid and simple test to diagnose microbial invasion of the amniotic cavity and predict preterm delivery. Am. J. Obstet. Gynecol. 165: 821-830.
14. Romero, R., M. Mazor, H. Munoz, R. Gomez, M. Galasso, and D. M. Sherer. 1994. The preterm labor syndrome. Ann. N. Y. Acad. Sci. 734: 414-429.
15. Andrews, W. W., J. C. Hauth, R. L. Goldenberg, R. Gomez, R. Romero, and G. H. Cassell. 1995. Amniotic fluid interleukin-6: correlation with upper genital tract microbial colonization and gestational age in women delivered after spontaneous labor versus indicated delivery. Am. J. Obstet. Gynecol. 173: 606-612.
16. Yoon, B. H., J. K. Jun, K. H. Park, H. C. Syn, R. Gomez, and R. Romero. 1996. Serum C-reactive protein, white blood cell count, and amniotic fluid white blood cell count in women with preterm premature rupture of membranes. Obstet. Gynecol. 88: 1034-1040.
17. Yoon, B. H., J. W. Chang, and R. Romero. 1998. Isolation of Ureaplasma urealyticum from the amniotic cavity and adverse outcome in preterm labor. Obstet. Gynecol. 92: 77-82.
18. Gomez, R., R. Romero, F. Ghezzi, B. H. Yoon, M. Mazor, and S. M. Berry. 1998. The fetal inflammatory response syndrome. Am. J. Obstet. Gynecol. 179: 194-202.
19. Yoon, B. H., R. Romero, M. Kim, E. C. Kim, T. Kim, J. S. Park, and J. K. Jun. 2000. Clinical implications of detection of Ureaplasma urealyticum in the amniotic cavity with the polymerase chain reaction. Am. J. Obstet. Gynecol. 183: 1130-1137.
20. Romero, R., R. Gómez, T. Chaiworapongsa, G. Conoscenti, J. C. Kim, and Y. M. Kim. 2001. The role of infection in preterm labour and delivery. Paediatr. Perinat. Epidemiol. 15(Suppl. 2): 41-56.
21. Yoon, B. H., R. Romero, J. B. Moon, S. S. Shim, M. Kim, G. Kim, and J. K. Jun. 2001. Clinical significance of intra - Amniotic inflammation in patients with preterm labor and intact membranes. Am. J. Obstet. Gynecol. 185: 1130-1136.
22. Jacobsson, B., I. Mattsby-Baltzer, B. Andersch, H. Bokström, R. M. Holst, U. B. Wennerholm, and H. Hagberg. 2003. Microbial invasion and cytokine response in amniotic fluid in a Swedish population of women in preterm labor. Acta Obstet. Gynecol. Scand. 82: 120-128.
23. Shim, S. S., R. Romero, J. S. Hong, C. W. Park, J. K. Jun, B. I. Kim, and B. H. Yoon. 2004. Clinical significance of intra - Amniotic inflammation in patients with preterm premature rupture of membranes. Am. J. Obstet. Gynecol. 191: 1339-1345.
24. Romero, R., J. Espinoza, L. F. Gonçalves, J. P. Kusanovic, L. Friel, and S. Hassan. 2007. The role of inflammation and infection in preterm birth. Semin. Reprod. Med. 25: 21-39.
25. Lee, S. E., R. Romero, H. Jung, C. W. Park, J. S. Park, and B. H. Yoon. 2007. The intensity of the fetal inflammatory response in intraamniotic inflammation with and without microbial invasion of the amniotic cavity. Am. J. Obstet. Gynecol. 197: 294.e1-6. doi:10.1016/j.ajog.2007.07.006
26. Kallapur, S. G., B. W. Kramer, C. L. Knox, C. A. Berry, J. J. Collins, M. W. Kemp, I. Nitsos, G. R. Polglase, J. Robinson, N. H. Hillman, et al. 2011. Chronic fetal exposure to Ureaplasma parvum suppresses innate immune re-sponses in sheep. J. Immunol. 187: 2688-2695.
27. Cobo, T., M. Palacio, M. Martinez-Terron, A. Navarro-Sastre, J. Bosch, X. Filella, and E. Gratacos. 2011. Clinical and inflammatory markers in amniotic fluid as predictors of adverse outcomes in preterm premature rupture of mem-branes. Am. J. Obstet. Gynecol. 205: 126.e1-8. doi:10.1016/j.ajog.2011.03.050
28. Agrawal, V., and E. Hirsch. 2012. Intrauterine infection and preterm labor. Semin. Fetal Neonatal Med. 17: 12-19.
29. Romero, R., J. Miranda, T. Chaiworapongsa, P. Chaemsaithong, F. Gotsch, Z. Dong, A. I. Ahmed, B. H. Yoon, S. S. Hassan, C. J. Kim, et al. 2014. Sterile intra - Amniotic inflammation in asymptomatic patients with a sonographic short cervix: prevalence and clinical significance. J. Matern. Fetal Neonatal Med. Sept. 24: 1-17.
30. Romero, R., J. Miranda, T. Chaiworapongsa, S. J. Korzeniewski, P. Chaemsaithong, F. Gotsch, Z. Dong, A. I. Ahmed, B. H. Yoon, S. S. Hassan, et al. 2014. Prevalence and clinical significance of sterile intra - Amniotic inflammation in patients with preterm labor and intact membranes. Am. J. Reprod. Immunol. 72: 458-474.
31. Romero, R., J. Miranda, T. Chaiworapongsa, P. Chaemsaithong, F. Gotsch, Z. Dong, A. I. Ahmed, B. H. Yoon, S. S. Hassan, C. J. Kim, et al. 2014. A novel molecular microbiologic technique for the rapid diagnosis of microbial invasion of the amniotic cavity and intra - Amniotic infection in preterm labor with intact membranes. Am. J. Reprod. Immunol. 71: 330-358.
32. Romero, R., J. Miranda, P. Chaemsaithong, T. Chaiworapongsa, J. P. Kusanovic, Z. Dong, A. I. Ahmed, M. Shaman, K. Lannaman, B. H. Yoon, et al. 2015. Sterile and microbial - Associated intra - Amniotic inflammation in preterm prelabor rupture of membranes. J. Matern. Fetal Neonatal Med. 28: 1394-1409.
33. Combs, C. A., M. Gravett, T. J. Garite, D. E. Hickok, J. Lapidus, R. Porreco, J. Rael, T. Grove, T. K. Morgan, W. Clewell, et al., and ProteoGenix/Obstetrix Collaborative Research Network. 2014. Amniotic fluid infection, inflammation, and colonization in preterm labor with intact membranes. Am. J. Obstet. Gynecol. 210: 125.e1-125.e15.
34. Kacerovsky, M., I. Musilova, C. Andrys, H. Hornychova, L. Pliskova, M. Kostal, and B. Jacobsson. 2014. Prelabor rupture of membranes between 34 and 37 weeks: the intraamniotic inflammatory response and neonatal outcomes. Am. J. Obstet. Gynecol. 210: 325.e1-325.e10. doi:10.1016/j.ajog.2013.10.882
35. Gervasi, M. T., T. Chaiworapongsa, N. Naccasha, S. Blackwell, B. H. Yoon, E. Maymon, and R. Romero. 2001. Phenotypic and metabolic characteristics of maternal monocytes and granulocytes in preterm labor with intact membranes. Am. J. Obstet. Gynecol. 185: 1124-1129.
36. Gervasi, M. T., T. Chaiworapongsa, N. Naccasha, P. Pacora, S. Berman, E. Maymon, J. C. Kim, Y. M. Kim, J. Yoshimatsu, J. Espinoza, and R. Romero. 2002. Maternal intravascular inflammation in preterm premature rupture of membranes. J. Matern. Fetal Neonatal Med. 11: 171-175.
37. Mittal, P., R. Romero, A. L. Tarca, S. Draghici, C. L. Nhan-Chang, T. Chaiworapongsa, J. Hotra, R. Gomez, J. P. Kusanovic, D. C. Lee, et al. 2011. A molecular signature of an arrest of descent in human parturition. Am. J. Obstet. Gynecol. 204: 177.e15-33.doi:10.1016/j.ajog.2010.09.025
38. Chaemsaithong, P., I. Madan, R. Romero, N. G. Than, A. L. Tarca, S. Draghici, G. Bhatti, L. Yeo, M. Mazor, C. J. Kim, et al. 2013. Characterization of the myometrial transcriptome in women with an arrest of dilatation during labor. J. Perinat. Med. 41: 665-681.
39. Kim, Y. M., R. Romero, T. Chaiworapongsa, G. J. Kim, M. R. Kim, H. Kuivaniemi, G. Tromp, J. Espinoza, E. Bujold, V. M. Abrahams, and G. Mor. 2004. Toll-like receptor-2 and-4 in the chorioamniotic membranes in spontaneous labor at term and in preterm parturition that are associated with cho-rioamnionitis. Am. J. Obstet. Gynecol. 191: 1346-1355.
40. Murphy, S. P., N. N. Hanna, L. D. Fast, S. K. Shaw, G. Berg, J. F. Padbury, R. Romero, and S. Sharma. 2009. Evidence for participation of uterine natural killer cells in the mechanisms responsible for spontaneous preterm labor and delivery. Am. J. Obstet. Gynecol. 200: 308.e1-9.doi:10.1016/j.ajog.2008.10.043
41. Koga, K., I. Cardenas, P. Aldo, V. M. Abrahams, B. Peng, S. Fill, R. Romero, and G. Mor. 2009. Activation of TLR3 in the trophoblast is associated with preterm delivery. Am. J. Reprod. Immunol. 61: 196-212.
42. Cardenas, I., R. E. Means, P. Aldo, K. Koga, S. M. Lang, C. J. Booth, A. Manzur, E. Oyarzun, R. Romero, and G. Mor. 2010. Viral infection of the placenta leads to fetal inflammation and sensitization to bacterial products predisposing to preterm labor. J. Immunol. 185: 1248-1257.
43. Cardenas, I., M. J. Mulla, K. Myrtolli, A. K. Sfakianaki, E. R. Norwitz, S. Tadesse, S. Guller, and V. M. Abrahams. 2011. Nod1 activation by bacterial iE-DAP induces maternal-fetal inflammation and preterm labor. J. Immunol. 187: 980-986.
44. Romero, R., T. Chaiworapongsa, Z. Alpay Savasan, Y. Xu, Y. Hussein, Z. Dong, J. P. Kusanovic, C. J. Kim, and S. S. Hassan. 2011. Damage - Associated molecular patterns (DAMPs) in preterm labor with intact membranes and preterm PROM: a study of the alarmin HMGB1. J. Matern. Fetal Neonatal Med. 24: 1444-1455.
45. Jaiswal, M. K., V. Agrawal, T. Mallers, A. Gilman-Sachs, E. Hirsch, and K. D. Beaman. 2013. Regulation of apoptosis and innate immune stimuli in inflammation-induced preterm labor. J. Immunol. 191: 5702-5713.
46. Shynlova, O., T. Nedd-Roderique, Y. Li, A. Dorogin, and S. J. Lye. 2013. Myometrial immune cells contribute to term parturition, preterm labour and post-partum involution in mice. J. Cell. Mol. Med. 17: 90-102.
47. Arenas-Hernandez, M., R. Romero, D. St Louis, S. S. Hassan, E. B. Kaye, and N. Gomez-Lopez. 2015. An imbalance between innate and adaptive immune cells at the maternal-fetal interface occurs prior to endotoxin-induced preterm birth. Cell. Mol. Immunol. DOI: 10.1038/cmi.2015.22.
48. Thaxton, J. E., T. A. Nevers, and S. Sharma. 2010. TLR-mediated preterm birth in response to pathogenic agents. Infect. Dis. Obstet. Gynecol. 2010: 2010.
49. Friel, L. A., R. Romero, S. Edwin, J. K. Nien, R. Gomez, T. Chaiworapongsa, J. P. Kusanovic, J. E. Tolosa, S. S. Hassan, and J. Espinoza. 2007. The calcium binding protein, S100B, is increased in the amniotic fluid of women with intra - Amniotic infection/inflammation and preterm labor with intact or ruptured membranes. J. Perinat. Med. 35: 385-393.
50. Romero, R., J. Espinoza, S. Hassan, F. Gotsch, J. P. Kusanovic, C. Avila, O. Erez, S. Edwin, and A. M. Schmidt. 2008. Soluble receptor for advanced glycation end products (sRAGE) and endogenous secretory RAGE (esRAGE) in amniotic fluid: modulation by infection and inflammation. J. Perinat. Med. 36: 388-398.
51. Chaiworapongsa, T., O. Erez, J. P. Kusanovic, E. Vaisbuch, S. Mazaki-Tovi, F. Gotsch, N. G. Than, P. Mittal, Y. M. Kim, N. Camacho, et al. 2008. Amniotic fluid heat shock protein 70 concentration in histologic chorioamnionitis, term and preterm parturition. J. Matern. Fetal Neonatal Med. 21: 449-461.
52. Lee, S. E., I. S. Park, R. Romero, and B. H. Yoon. 2009. Amniotic fluid prostaglandin F2 increases even in sterile amniotic fluid and is an independent predictor of impending delivery in preterm premature rupture of membranes. J. Matern. Fetal Neonatal Med. 22: 880-886.
53. Lotze, M. T., A. Deisseroth, and A. Rubartelli. 2007. Damage associated molecular pattern molecules. Clin. Immunol. 124: 1-4.
54. Oppenheim, J. J., and D. Yang. 2005. Alarmins: chemotactic activators of immune responses. Curr. Opin. Immunol. 17: 359-365.
55. Chen, G. Y., and G. Nun-ez. 2010. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 10: 826-837.
56. Espinoza, J., R. Romero, T. Chaiworapongsa, J. C. Kim, J. Yoshimatsu, S. Edwin, C. Rathnasabapathy, J. Tolosa, A. Donnenfeld, F. Craparo, et al. 2002. Lipopolysaccharide-binding protein in microbial invasion of the amniotic cavity and human parturition. J. Matern. Fetal Neonatal Med. 12: 313-321.
57. Romero, R., J. Miranda, P. Chaemsaithong, T. Chaiworapongsa, J. P. Kusanovic, Z. Dong, A. I. Ahmed, M. Shaman, K. Lannaman, B. H. Yoon, et al. 2015. Sterile and microbial - Associated intra - Amniotic inflammation in preterm prelabor rupture of membranes. J. Matern. Fetal Neonatal Med. 28: 1394-1409.
58. Romero, R., M. Mazor, and B. Tartakovsky. 1991. Systemic administration of interleukin-1 induces preterm parturition in mice. Am. J. Obstet. Gynecol. 165: 969-971.
59. Gomez-Lopez, N., R. Romero, O. Plazyo, B. Panaitescu, A. E. Furcron, D. Miller, T. Roumayah, E. Flom, and S. A. Hassan. 2016. Intra - Amniotic administration of HMGB1 induces spontaneous preterm labor and birth. Am. J. Reprod. Immunol. In press.
60. Cayrol, C., and J. P. Girard. 2009. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc. Natl. Acad. Sci. USA 106: 9021-9026.
61. Topping, V., R. Romero, N. G. Than, A. L. Tarca, Z. Xu, S. Y. Kim, B. Wang, L. Yeo, C. J. Kim, S. S. Hassan, and J. S. Kim. 2013. Interleukin-33 in the human placenta. J. Matern. Fetal Neonatal Med. 26: 327-338.
62. Kim, C. J., R. Romero, P. Chaemsaithong, N. Chaiyasit, B. H. Yoon, and Y. M. Kim. 2015. Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance. Am. J. Obstet. Gynecol. 213(4, Suppl.)S29-S52.
63. Bourgeois, E., L. P. Van, M. Samson, S. Diem, A. Barra, S. Roga, J. M. Gombert, E. Schneider, M. Dy, P. Gourdy, et al. 2009. The pro-Th2 cy-tokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production. Eur. J. Immunol. 39: 1046-1055.
64. Smithgall, M. D., M. R. Comeau, B. R. Yoon, D. Kaufman, R. Armitage, and D. E. Smith. 2008. IL-33 amplifies both Th1 - And Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int. Immunol. 20: 1019-1030.
65. Kitamura, H., K. Iwakabe, T. Yahata, S. Nishimura, A. Ohta, Y. Ohmi, M. Sato, K. Takeda, K. Okumura, L. Van Kaer, et al. 1999. The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J. Exp. Med. 189: 1121-1128.
66. Tomura, M., W. G. Yu, H. J. Ahn, M. Yamashita, Y. F. Yang, S. Ono, T. Hamaoka, T. Kawano, M. Taniguchi, Y. Koezuka, and H. Fujiwara. 1999. A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system. J. Immunol. 163: 93-101.
67. Fujii, S., K. Shimizu, M. Kronenberg, and R. M. Steinman. 2002. Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs. Nat. Immunol. 3: 867-874.
68. Brigl, M., L. Bry, S. C. Kent, J. E. Gumperz, and M. B. Brenner. 2003. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol. 4: 1230-1237.
69. Oki, S., A. Chiba, T. Yamamura, and S. Miyake. 2004. The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells. J. Clin. Invest. 113: 1631-1640.
70. Sag, D., P. Krause, C. C. Hedrick, M. Kronenberg, and G. Wingender. 2014. IL-10-producing NKT10 cells are a distinct regulatory invariant NKT cell subset. J. Clin. Invest. 124: 3725-3740.
71. Bendelac, A., P. B. Savage, and L. Teyton. 2007. The biology of NKT cells. Annu. Rev. Immunol. 25: 297-336.
72. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, et al. 1997. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278: 1626-1629.
73. Sidobre, S., O. V. Naidenko, B. C. Sim, N. R. Gascoigne, K. C. Garcia, and M. Kronenberg. 2002. The V alpha 14 NKT cell TCR exhibits high - Affinity binding to a glycolipid/CD1d complex. J. Immunol. 169: 1340-1348.
74. Lehmann, J. M., L. B. Moore, T. A. Smith-Oliver, W. O. Wilkison, T. M. Willson, and S. A. Kliewer. 1995. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator - Activated receptor gamma (PPAR gamma). J. Biol. Chem. 270: 12953-12956.
75. Ricote, M., A. C. Li, T. M. Willson, C. J. Kelly, and C. K. Glass. 1998. The peroxisome proliferator - Activated receptor-gamma is a negative regulator of macrophage activation. Nature 391: 79-82.
76. Chinetti, G., S. Griglio, M. Antonucci, I. P. Torra, P. Delerive, Z. Majd, J. C. Fruchart, J. Chapman, J. Najib, and B. Staels. 1998. Activation of proliferator - Activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages. J. Biol. Chem. 273: 25573-25580.
77. Delerive, P., F. Martin-Nizard, G. Chinetti, F. Trottein, J. C. Fruchart, J. Najib, P. Duriez, and B. Staels. 1999. Peroxisome proliferator - Activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway. Circ. Res. 85: 394-402.
78. McCarthy, F. P., A. C. Delany, L. C. Kenny, and S. K. Walsh. 2013. PPAR-g - A possible drug target for complicated pregnancies. Br. J. Pharmacol. 168: 1074-1085.
79. Forman, B. M., P. Tontonoz, J. Chen, R. P. Brun, B. M. Spiegelman, and R. M. Evans. 1995. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83: 803-812.
80. Kliewer, S. A., J. M. Lenhard, T. M. Willson, I. Patel, D. C. Morris, and J. M. Lehmann. 1995. A prostaglandin J2 metabolite binds peroxisome proliferator - Activated receptor gamma and promotes adipocyte differentiation. Cell 83: 813-819.
81. Pirianov, G., S. N. Waddington, T. M. Lindström, V. Terzidou, H. Mehmet, and P. R. Bennett. 2009. The cyclopentenone 15-deoxy-delta 12, 14-prostaglandin J(2) delays lipopolysaccharide-induced preterm delivery and reduces mortality in the newborn mouse. Endocrinology 150: 699-706.
82. Arenas-Hernandez, M., E. N. Sanchez-Rodriguez, T. N. Mial, S. A. Robertson, and N. Gomez-Lopez. 2015. Isolation of leukocytes from the murine tissues at the maternal-fetal interface. J. Vis. Exp. 99: e52866.
83. American College of Obstetrics and Gynecology Committee on Practice Bulletins-Obstetrics. 2003. ACOG Practice Bulletin Number 49, December 2003: Dystocia and augmentation of labor. Obstet. Gynecol. 102: 1445-1454.
84. Redline, R. W. 2008. Placental pathology: a systematic approach with clinical correlations. Placenta 29 Suppl. A: S86-91. doi:10.1016/j.placenta. 2007.09.003
85. Kim, C. J., R. Romero, J. P. Kusanovic, W. Yoo, Z. Dong, V. Topping, F. Gotsch, B. H. Yoon, J. G. Chi, and J. S. Kim. 2010. The frequency, clinical significance, and pathological features of chronic chorioamnionitis: a lesion associated with spontaneous preterm birth. Mod. Pathol. 23: 1000-1011.
86. Xu, Y., O. Plazyo, R. Romero, S. S. Hassan, and N. Gomez-Lopez. 2015. Isolation of leukocytes from the human maternal-fetal interface. J. Vis. Exp. 99: e52863.
87. Rochelson, B. L., H. Schulman, A. Fleischer, G. Farmakides, L. Bracero, J. Ducey, D. Winter, and B. Penny. 1987. The clinical significance of Doppler umbilical artery velocimetry in the small for gestational age fetus. Am. J. Obstet. Gynecol. 156: 1223-1226.
88. Schulman, H. 1987. The clinical implications of Doppler ultrasound analysis of the uterine and umbilical arteries. Am. J. Obstet. Gynecol. 156: 889-893.
89. 1995. ACOG technical bulletin. Fetal heart rate patterns: monitoring, inter-pretation, and management. Number 207-July 1995 (replaces No. 132, September 1989). Int. J. Gynaecol. Obstet. 51: 65-74.
90. The National Institute of Child Health and Human Development Research Planning Workshop. 1997. Electronic fetal heart rate monitoring: research guidelines for interpretation. J. Obstet. Gynecol. Neonatal Nurs. 26: 635-640.
91. Boyson, J. E., N. Nagarkatti, L. Nizam, M. A. Exley, and J. L. Strominger. 2006. Gestation stage-dependent mechanisms of invariant natural killer T cell-mediated pregnancy loss. Proc. Natl. Acad. Sci. USA 103: 4580-4585.
92. Ito, K., M. Karasawa, T. Kawano, T. Akasaka, H. Koseki, Y. Akutsu, E. Kondo, S. Sekiya, K. Sekikawa, M. Harada, et al. 2000. Involvement of decidual Valpha14 NKT cells in abortion. Proc. Natl. Acad. Sci. USA 97: 740-744.
93. Szatmari, I., P. Gogolak, J. S. Im, B. Dezso, E. Rajnavolgyi, and L. Nagy. 2004. Activation of PPARgamma specifies a dendritic cell subtype capable of enhanced induction of iNKT cell expansion. Immunity 21: 95-106.
94. Frohnert, B. I., T. Y. Hui, and D. A. Bernlohr. 1999. Identification of a functional peroxisome proliferator-responsive element in the murine fatty acid transport protein gene. J. Biol. Chem. 274: 3970-3977.
95. Chiu, Y. H., J. Jayawardena, A. Weiss, D. Lee, S. H. Park, A. Dautry-Varsat, and A. Bendelac. 1999. Distinct subsets of CD1d-restricted T cells recognize self - Antigens loaded in different cellular compartments. J. Exp. Med. 189: 103-110.
96. Crowe, N. Y., J. M. Coquet, S. P. Berzins, K. Kyparissoudis, R. Keating, D. G. Pellicci, Y. Hayakawa, D. I. Godfrey, and M. J. Smyth. 2005. Differential antitumor immunity mediated by NKT cell subsets in vivo. J. Exp. Med. 202: 1279-1288.
97. Terabe, M., J. Swann, E. Ambrosino, P. Sinha, S. Takaku, Y. Hayakawa, D. I. Godfrey, S. Ostrand-Rosenberg, M. J. Smyth, and J. A. Berzofsky. 2005. A nonclassical non-Valpha14Jalpha18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance. J. Exp. Med. 202: 1627-1633.
98. Zheng, Q., L. Zhou, and Q. S. Mi. 2012. MicroRNA miR-150 is involved in Va14 invariant NKT cell development and function. J. Immunol. 188: 2118-2126.
99. Taniguchi, M., K. Seino, and T. Nakayama. 2003. The NKT cell system: bridging innate and acquired immunity. Nat. Immunol. 4: 1164-1165.
100. Carnaud, C., D. Lee, O. Donnars, S. H. Park, A. Beavis, Y. Koezuka, and A. Bendelac. 1999. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163: 4647-4650.
101. Singh, N., S. Hong, D. C. Scherer, I. Serizawa, N. Burdin, M. Kronenberg, Y. Koezuka, and L. Van Kaer. 1999. Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acqui-sition of a Th2 phenotype. J. Immunol. 163: 2373-2377.
102. Nishimura, T., H. Kitamura, K. Iwakabe, T. Yahata, A. Ohta, M. Sato, K. Takeda, K. Okumura, L. Van Kaer, T. Kawano, et al. 2000. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes. Int. Immunol. 12: 987-994.
103. Kitamura, H., A. Ohta, M. Sekimoto, M. Sato, K. Iwakabe, M. Nakui, T. Yahata, H. Meng, T. Koda, S. Nishimura, et al. 2000. alpha-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells. Cell. Immunol. 199: 37-42.
104. Wang, H., D. Feng, O. Park, S. Yin, and B. Gao. 2013. Invariant NKT cell activation induces neutrophil accumulation and hepatitis: opposite regulation by IL-4 and IFN-g. Hepatology 58: 1474-1485.
105. Fujii, S., K. Shimizu, C. Smith, L. Bonifaz, and R. M. Steinman. 2003. Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J. Exp. Med. 198: 267-279.
106. Xue, J., S. V. Schmidt, J. Sander, A. Draffehn, W. Krebs, I. Quester, D. De Nardo, T. D. Gohel, M. Emde, L. Schmidleithner, et al. 2014. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 40: 274-288.
107. Murray, P. J., J. E. Allen, S. K. Biswas, E. A. Fisher, D. W. Gilroy, S. Goerdt, S. Gordon, J. A. Hamilton, L. B. Ivashkiv, T. Lawrence, et al. 2014. Macro-phage activation and polarization: nomenclature and experimental guidelines. Immunity 41: 14-20.
108. Mills, C. D., K. Kincaid, J. M. Alt, M. J. Heilman, and A. M. Hill. 2000. M-1/M-2 macrophages and the Th1/Th2 paradigm. J. Immunol. 164: 6166-6173.
109. Mantovani, A., S. Sozzani, M. Locati, P. Allavena, and A. Sica. 2002. Mac-rophage polarization: tumor - Associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23: 549-555.
110. Biswas, S. K., and A. Mantovani. 2010. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 11: 889-896.
111. Sica, A., and A. Mantovani. 2012. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 122: 787-795.
112. Ellis, T. N., and B. L. Beaman. 2002. Murine polymorphonuclear neutrophils produce interferon-gamma in response to pulmonary infection with Nocardia asteroides. J. Leukoc. Biol. 72: 373-381.
113. Ethuin, F., B. Gérard, J. E. Benna, A. Boutten, M. A. Gougereot-Pocidalo, L. Jacob, and S. Chollet-Martin. 2004. Human neutrophils produce interferon gamma upon stimulation by interleukin-12. Lab. Invest. 84: 1363-1371.
114. Boyson, J. E., B. Rybalov, L. A. Koopman, M. Exley, S. P. Balk, F. K. Racke, F. Schatz, R. Masch, S. B. Wilson, and J. L. Strominger. 2002. CD1d and invariant NKT cells at the human maternal-fetal interface. Proc. Natl. Acad. Sci. USA 99: 13741-13746.
115. Li, L. P., Y. C. Fang, G. F. Dong, Y. Lin, and S. Saito. 2012. Depletion of invariant NKT cells reduces inflammation-induced preterm delivery in mice. J. Immunol. 188: 4681-4689.
116. Li, L., J. Yang, Y. Jiang, J. Tu, and D. J. Schust. 2015. Activation of decidual invariant natural killer T cells promotes lipopolysaccharide-induced preterm birth. Mol. Hum. Reprod. 21: 369-381.
117. Mattner, J., K. L. Debord, N. Ismail, R. D. Goff, C. Cantu, III, D. Zhou, P. Saint-Mezard, V. Wang, Y. Gao, N. Yin, et al. 2005. Exogenous and en-dogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434: 525-529.
118. Aluvihare, V. R., M. Kallikourdis, and A. G. Betz. 2004. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol. 5: 266-271.
119. Rowe, J. H., J. M. Ertelt, L. Xin, and S. S. Way. 2012. Pregnancy imprints regulatory memory that sustains anergy to fetal antigen. Nature 490: 102-106.
120. Shima, T., Y. Sasaki, M. Itoh, A. Nakashima, N. Ishii, K. Sugamura, and S. Saito. 2010. Regulatory T cells are necessary for implantation and maintenance of early pregnancy but not late pregnancy in allogeneic mice. J. Reprod. Immunol. 85: 121-129.
121. Wang, M. L., D. J. Dorer, M. P. Fleming, and E. A. Catlin. 2004. Clinical outcomes of near-term infants. Pediatrics 114: 372-376.
122. Raju, T. N., R. D. Higgins, A. R. Stark, and K. J. Leveno. 2006. Optimizing care and outcome for late-preterm (near-term) infants: a summary of the workshop sponsored by the National Institute of Child Health and Human Development. Pediatrics 118: 1207-1214.
123. Pellicci, D. G., K. J. Hammond, A. P. Uldrich, A. G. Baxter, M. J. Smyth, and D. I. Godfrey. 2002. A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(2)CD4(+) CD1d-dependent precursor stage. J. Exp. Med. 195: 835-844.
124. Dunn-Albanese, L. R., W. E. Ackerman, IV, Y. Xie, J. D. Iams, and D. A. Kniss. 2004. Reciprocal expression of peroxisome proliferator - Activated receptor-gamma and cyclooxygenase-2 in human term parturition. Am. J. Obstet. Gynecol. 190: 809-816.
125. Mial, N. T., L. Kadam, R. Romero, S. Drewlo, and N. Gomez-Lopez. 2015. Rosiglitazone treatment rapidly controls the systemic pro-inflammatory response and reduces the rate of infection-induced preterm birth. Reprod. Sci. 22: 137A (Abstr.).
126. Crowe, N. Y., A. P. Uldrich, K. Kyparissoudis, K. J. Hammond, Y. Hayakawa, S. Sidobre, R. Keating, M. Kronenberg, M. J. Smyth, and D. I. Godfrey. 2003. Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells. J. Immunol. 171: 4020-4027.
127. Szatmari, I., A. Pap, R. Rühl, J. X. Ma, P. A. Illarionov, G. S. Besra, E. Rajnavolgyi, B. Dezso, and L. Nagy. 2006. PPARgamma controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cells. J. Exp. Med. 203: 2351-2362.
128. Brossay, L., D. Jullien, S. Cardell, B. C. Sydora, N. Burdin, R. L. Modlin, and M. Kronenberg. 1997. Mouse CD1 is mainly expressed on hemopoietic-derived cells. J. Immunol. 159: 1216-1224.
129. Roark, J. H., S. H. Park, J. Jayawardena, U. Kavita, M. Shannon, and A. Bendelac. 1998. CD1.1 expression by mouse antigen-presenting cells and marginal zone B cells. J. Immunol. 160: 3121-3127.
130. Bendelac, A. 1995. Positive selection of mouse NK1+ T cells by CD1-expressing cortical thymocytes. J. Exp. Med. 182: 2091-2096.
131. Gomez-Lopez, N., L. J. Guilbert, and D. M. Olson. 2010. Invasion of the leukocytes into the fetal-maternal interface during pregnancy. J. Leukoc. Biol. 88: 625-633.
132. Gomez-Lopez, N., D. StLouis, M. A. Lehr, E. N. Sanchez-Rodriguez, and M. Arenas-Hernandez. 2014. Immune cells in term and preterm labor. Cell. Mol. Immunol. 11: 571-581.
133. Bizargity, P., R. Del Rio, M. Phillippe, C. Teuscher, and E. A. Bonney. 2009. Resistance to lipopolysaccharide-induced preterm delivery mediated by regulatory T cell function in mice. Biol. Reprod. 80: 874-881.
134. Gomez-Lopez, N., L. Vadillo-Perez, A. Hernandez-Carbajal, M. Godines-Enriquez, D. M. Olson, and F. Vadillo-Ortega. 2011. Specific inflammatory microenvironments in the zones of the fetal membranes at term delivery. Am. J. Obstet. Gynecol. 205: 235.e15-24. doi:10.1016/j.ajog.2011.04.019
135. Gomez-Lopez, N., R. Vega-Sanchez, M. Castillo-Castrejon, R. Romero, K. Cubeiro-Arreola, and F. Vadillo-Ortega. 2013. Evidence for a role for the adaptive immune response in human term parturition. Am. J. Reprod. Immunol. 69: 212-230.
136. Gomez-Lopez, N., D. M. Olson, and S. A. Robertson. 2015. Interleukin-6 controls uterine Th9 cells and CD8 T regulatory cells to accelerate parturi-tion in mice. Immunol. Cell Biol. DOI: 10.1038/icb.2015.63.
137. Marx, N., B. Kehrle, K. Kohlhammer, M. Grüb, W. Koenig, V. Hombach, P. Libby, and J. Plutzky. 2002. PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation - Associated arteriosclerosis. Circ. Res. 90: 703-710.
138. Yang, X. Y., L. H. Wang, T. Chen, D. R. Hodge, J. H. Resau, L. DaSilva, and W. L. Farrar. 2000. Activation of human T lymphocytes is inhibited by per-oxisome proliferator - Activated receptor gamma (PPARgamma) agonists. PPARgamma co - Association with transcription factor NFAT. J. Biol. Chem. 275: 4541-4544.
139. Gonzalez, J. M., C. W. Franzke, F. Yang, R. Romero, and G. Girardi. 2011. Complement activation triggers metalloproteinases release inducing cervical remodeling and preterm birth in mice. Am. J. Pathol. 179: 838-849.
140. Jiang, C., A. T. Ting, and B. Seed. 1998. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391: 82-86.
141. Kintscher, U., S. Goetze, S. Wakino, S. Kim, S. Nagpal, R. A. Chandraratna, K. Graf, E. Fleck, W. A. Hsueh, and R. E. Law. 2000. Peroxisome proliferator - Activated receptor and retinoid X receptor ligands inhibit monocyte che-motactic protein-1-directed migration of monocytes. Eur. J. Pharmacol. 401: 259-270.
142. Rinaldi, S. F., R. D. Catalano, J. Wade, A. G. Rossi, and J. E. Norman. 2014. Decidual neutrophil infiltration is not required for preterm birth in a mouse model of infection-induced preterm labor. J. Immunol. 192: 2315-2325.
143. Reddy, R. C., V. R. Narala, V. G. Keshamouni, J. E. Milam, M. W. Newstead, and T. J. Standiford. 2008. Sepsis-induced inhibition of neutrophil chemotaxis is mediated by activation of peroxisome proliferator - Activated receptor-gamma. Blood 112: 4250-4258.
144. Blois, S. M., C. D. Alba Soto, M. Tometten, B. F. Klapp, R. A. Margni, and P. C. Arck. 2004. Lineage, maturity, and phenotype of uterine murine dendritic cells throughout gestation indicate a protective role in maintaining pregnancy. Biol. Reprod. 70: 1018-1023.
145. Bizargity, P., and E. A. Bonney. 2009. Dendritic cells: a family portrait at mid-gestation. Immunology 126: 565-578.
146. Faveeuw, C., S. Fougeray, V. Angeli, J. Fontaine, G. Chinetti, P. Gosset, P. Delerive, C. Maliszewski, M. Capron, B. Staels, et al. 2000. Peroxisome proliferator - Activated receptor gamma activators inhibit interleukin-12 pro-duction in murine dendritic cells. FEBS Lett. 486: 261-266.
147. Romero, R., K. R. Manogue, M. D. Mitchell, Y. K. Wu, E. Oyarzun, J. C. Hobbins, and A. Cerami. 1989. Infection and labor. IV. Cachectin-tumor necrosis factor in the amniotic fluid of women with intraamniotic infection and preterm labor. Am. J. Obstet. Gynecol. 161: 336-341.
148. Casey, M. L., S. M. Cox, B. Beutler, L. Milewich, and P. C. MacDonald. 1989. Cachectin/tumor necrosis factor - Alpha formation in human decidua. Potential role of cytokines in infection-induced preterm labor. J. Clin. Invest. 83: 430-436.
149. Romero, R., M. Mazor, W. Sepulveda, C. Avila, D. Copeland, and J. Williams. 1992. Tumor necrosis factor in preterm and term labor. Am. J. Obstet. Gynecol. 166: 1576-1587.
150. Jacobsson, B., R. M. Holst, U. B. Wennerholm, B. Andersson, H. Lilja, and H. Hagberg. 2003. Monocyte chemotactic protein-1 in cervical and amniotic fluid: relationship to microbial invasion of the amniotic cavity, intra - Amniotic inflammation, and preterm delivery. Am. J. Obstet. Gynecol. 189: 1161-1167.
151. Esplin, M. S., M. R. Peltier, S. Hamblin, S. Smith, M. B. Fausett, G. A. Dildy, D. W. Branch, R. M. Silver, and E. Y. Adashi. 2005. Monocyte chemotactic protein-1 expression is increased in human gestational tissues during term and preterm labor. Placenta 26: 661-671.
152. Esplin, M. S., R. Romero, T. Chaiworapongsa, Y. M. Kim, S. Edwin, R. Gomez, M. Mazor, and E. Y. Adashi. 2005. Monocyte chemotactic protein-1 is increased in the amniotic fluid of women who deliver preterm in the presence or absence of intra - Amniotic infection. J. Matern. Fetal Neonatal Med. 17: 365-373.
153. Törnblom, S. A., A. Klimaviciute, B. Byström, M. Chromek, A. Brauner, and G. Ekman-Ordeberg. 2005. Non-infected preterm parturition is related to increased concentrations of IL-6, IL-8 and MCP-1 in human cervix. Reprod. Biol. Endocrinol. 3: 39.
154. Shynlova, O., P. Tsui, A. Dorogin, and S. J. Lye. 2008. Monocyte chemo - Attractant protein-1 (CCL-2) integrates mechanical and endocrine signals that mediate term and preterm labor. J. Immunol. 181: 1470-1479.
155. Romero, R., J. C. Grivel, A. L. Tarca, P. Chaemsaithong, Z. Xu, W. Fitzgerald, S. S. Hassan, T. Chaiworapongsa, and L. Margolis. 2015. Evidence of perturbations of the cytokine network in preterm labor. Am. J. Obstet. Gynecol. July 29. pii: S0002-9378(15)00787-5.
156. Lappas, M., M. Permezel, H. M. Georgiou, and G. E. Rice. 2002. Regulation of proinflammatory cytokines in human gestational tissues by peroxisome proliferator - Activated receptor-gamma: effect of 15-deoxy-Delta(12, 14)-PGJ(2) and troglitazone. J. Clin. Endocrinol. Metab. 87: 4667-4672.
157. Meier, C. A., R. Chicheportiche, C. E. Juge-Aubry, M. G. Dreyer, and J. M. Dayer. 2002. Regulation of the interleukin-1 receptor antagonist in THP-1 cells by ligands of the peroxisome proliferator - Activated receptor gamma. Cy-tokine 18: 320-328.